US-based aesthetic medical products manufacturer Mentor Worldwide has received the US Food and Drug Administration (FDA) clearance for its MemoryShape breast implants.

Indicated for breast reconstruction and breast augmentation in women who are aged at least 22 years, the MemoryShape breast implants use a teardrop shape that is similar to the silhouette of a natural breast and come with a gel formulation for optimal shape and feel.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The breast implants can be sized using the BodyLogic system, an implant sizing system that enables surgeons to determine the right breast implants for patients based on their individual requirements.

Mentor worldwide president David J Wilson said the company recognises that different patients have varying needs and reasons for choosing to undergo breast surgery.

“The MemoryShape breast implants use a teardrop shape that is similar to the silhouette of a natural breast and come with a gel formulation for optimal shape and feel.”

“The FDA approval of Mentor MemoryShape breast implants allows us to meet this need by delivering the perfect balance of shape and feel to obtain the natural and youthful look patients desire,” Wilson said.

The approval was based on the open-label, multicentre MemoryShape breast implant core study, which involved 955 patients who underwent post-surgery follow up annually for ten years in order to evaluate the safety and effectiveness of the implants.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

According to Mentor, during the clinical trial it was found that the breast implants were safe and effective in both reconstruction and augmentation patients at six years, with a low rate of adverse cases such as rupture and capsular contracture Baker grades III and IV.

On the whole, the patients reported high satisfaction rates with their breast appearance, with about 97% reporting that they would repeat the process.

Following the FDA approval, the company now plans to conduct studies to gather additional clinical data on the implants.